NCT00001223Terminated
Diagnosis and Treatment of Patients With Cystic Fibrosis
Source: ClinicalTrials.gov · Last updated 4 Feb 2026
Reason given: PI left NIH
Brief summary (registry, in English)
This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.
- Status (registry)
- Terminated
- Study type
- Observational
- Enrollment
- 79 (actual)
- First submitted
- 3 Nov 1999
- Start date
- 1 Jan 1988
- Primary completion date
- 30 Jan 2026
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Diseases
- Cystic fibrosis
- NCT number
- NCT00001223
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- -Concomitant medical, psychiatric or other problems which might complicate interpretation of studies of CF, or for which we are unable to provide adequate care.
Criteria the registry did not label
- INCLUSION CRITERIA
- Patients with known or suspected CF and family members of patients with CF.
- >=4 years of age
Age in the registry: 4 years to 120 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.